Musaffa's Global Halal Trading Platform is Here!
Start Investing NowSUPN Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: November 14, 2025
Report Source: 2025 3rd Quarter Report
Supernus Pharmaceuticals Inc. Stock Analysis SUPN
United States Health Care Mid Cap Report: Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. The company is headquartered in Rockville, Maryland and currently employs 674 full-time employees. The company went IPO on 2010-12-28. The Company’s diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson’s disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. The company is also developing a range of product candidates for CNS disorders. Its commercial products that it markets include Qelbree, GOCOVRI, Oxtellar XR, Trokendi XR, APOKYN, XADAGO, MYOBLOC and ONAPGO. Its ONAPGO injection is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced PD. The company also offers ZURZUVAE (zuranolone) capsules CIV, which is a U.S. FDA-approved oral medicine indicated for the treatment of adults with postpartum depression.
Read More Supernus Pharmaceuticals Inc (SUPN) Chart
Supernus Pharmaceuticals Inc (SUPN) vs CBOE Volatility Index (VIX) Comparative Returns
Analysis of Supernus Pharmaceuticals Inc (SUPN) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.
YTD Performance
- Supernus Pharma... (SUP...) 0.3%
- CBOE Volatility Index (VIX) 7.42%
Supernus Pharma... Underperformed CBOE Volatility Index (VIX) by 7.12%
1Y Performance
- Supernus Pharma... (SUP...) 27.85%
- CBOE Volatility Index (VIX) -3.02%
Supernus Pharma... Outperformed CBOE Volatility Index (VIX) by 30.87%
3Y Performance
- Supernus Pharma... (SUP...) 26.39%
- CBOE Volatility Index (VIX) -19.46%
Supernus Pharma... Outperformed CBOE Volatility Index (VIX) by 45.85%
5Y Performance
- Supernus Pharma... (SUP...) 63.07%
- CBOE Volatility Index (VIX) -51.47%
Supernus Pharma... Outperformed CBOE Volatility Index (VIX) by 114.54%
Key Statistics of Supernus Pharmaceuticals Inc (SUPN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$51.37Volume
675.93KP/E Ratio (TTM)
39.4752 Week Range
Market Cap
2.76BAvg. Volume
691.29KDividend Yield
-Financial Metrics & Statements of Supernus Pharmaceuticals Inc (SUPN)
Super Investors Invested in Supernus Pharmaceuticals Inc (SUPN)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Third Avenue Management
% Portfolio:
1.24 Recent Activity:-
Robert Bruce
% Portfolio:
0.86 Recent Activity:-
Keeley-Teton Advisors, LLC
% Portfolio:
0.07 Recent Activity:36.38%
Jefferies Group
% Portfolio:
0.04 Recent Activity:61.99%
Community-Curated Collections with Supernus Pharmaceuticals Inc (SUPN) ( With SUPN )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's for Supernus Pharmaceuticals Inc (SUPN)
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Related Halal Stocks to Supernus Pharmaceuticals Inc (SUPN)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
